538 related articles for article (PubMed ID: 9856563)
1. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
Zatz M; Otto PA
Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
[TBL] [Abstract][Full Text] [Related]
3. Serum myoglobin in muscular dystrophy.
Kagen LJ; Moussavi S; Miller SL; Tsairis P
Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
[TBL] [Abstract][Full Text] [Related]
4. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
[TBL] [Abstract][Full Text] [Related]
5. X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers.
Wenger SL; Steele MW; Hoffman EP; Barmada MA; Wessel HB
Am J Med Genet; 1992 Aug; 43(6):1012-5. PubMed ID: 1415326
[TBL] [Abstract][Full Text] [Related]
6. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
Zatz M; Frota-Pessoa O; Levy JA; Peres CA
J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
[TBL] [Abstract][Full Text] [Related]
7. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
Percy ME; Andrews DF; Thompson MW
Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
[TBL] [Abstract][Full Text] [Related]
8. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
Passos MR; Gonzalez CH; Zatz M
Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
[TBL] [Abstract][Full Text] [Related]
9. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
Vainzof M; Zatz M; Otto PA
Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
[TBL] [Abstract][Full Text] [Related]
10. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts.
Davis MH; Cappel R; Vester JW; Samaha FJ; Gruenstein E
Muscle Nerve; 1982 Jan; 5(1):1-6. PubMed ID: 7057800
[TBL] [Abstract][Full Text] [Related]
11. Becker and Duchenne muscular dystrophy: a comparative morphological study.
Dennett X; Shield LK; Clingan LJ; Woolley DA
Aust Paediatr J; 1988; 24 Suppl 1():15-20. PubMed ID: 3202735
[TBL] [Abstract][Full Text] [Related]
12. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
Percy ME; Andrews DF; Thompson MW
Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
[TBL] [Abstract][Full Text] [Related]
14. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy.
Zatz M; Rapaport D; Vainzof M; Passos-Bueno MR; Bortolini ER; Pavanello Rde C; Peres CA
J Neurol Sci; 1991 Apr; 102(2):190-6. PubMed ID: 2072118
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic female carriers of Duchenne muscular dystrophy (DMD): genetic and clinical characterization.
Giliberto F; Radic CP; Luce L; Ferreiro V; de Brasi C; Szijan I
J Neurol Sci; 2014 Jan; 336(1-2):36-41. PubMed ID: 24135430
[TBL] [Abstract][Full Text] [Related]
16. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
[TBL] [Abstract][Full Text] [Related]
17. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of X-linked progressive muscular dystrophy in Campania.
Nigro G; Comi LI; Limongelli FM; Giugliano MA; Politano L; Petretta V; Passamano L; Stefanelli S
Muscle Nerve; 1983 May; 6(4):253-62. PubMed ID: 6683357
[TBL] [Abstract][Full Text] [Related]
19. [Manifesting carriers of Duchenne muscular dystrophy over two generations].
Itagaki Y; Saida K; Nishitani H; Matsuo M; Nishio H
Rinsho Shinkeigaku; 1993 Apr; 33(4):377-81. PubMed ID: 8103723
[TBL] [Abstract][Full Text] [Related]
20. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
